4//SEC Filing
Murdoch Travis 4
Accession 0001645842-22-000142
CIK 0001645842other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 7:48 PM ET
Size
392.1 KB
Accession
0001645842-22-000142
Insider Transaction Report
Form 4
Murdoch Travis
Director
Transactions
- Disposition to Issuer
Common Stock
2022-10-19−79,697→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo. Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer restricted stock units ("RSUs") vested in full pursuant to the terms of the agreements governing such Issuer RSUs. Pursuant to the Merger Agreement, immediately prior to the Effective Time, the Issuer RSUs were cancelled and converted into a right to receive the Merger Consideration in respect of such Issuer RSUs and cash in lieu of any fractional shares of Class A common stock of Ginkgo.
Issuer
Zymergen Inc.
CIK 0001645842
Entity typeother
Related Parties
1- filerCIK 0001845681
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 7:48 PM ET
- Size
- 392.1 KB